weekly semaglutide dose (Ozempic® / Wegovy®) for Weight Loss: Benefits, Dosage & Safety Wegovy Doses Explained: Dosage Chart

Begin application from the forehead and move downwards to the neck

Clinical trials show semaglutide users typically lose 1022% of baseline body weight over 68 weeks, with some patients achieving losses exceeding 20%

Your physician monitors progress through regular check-ins and lab work to adjust the protocol as needed

A randomized, triple-blind, placebo-controlled trial

Upon injection, deoxycholic acid breaks down fat cell membranes through adipocytolysis , causing irreversible fat cell destruction

The study also found that after 72 weeks: The STEP-1 trial, on the other hand, investigated the effectiveness of Wegovy and found that after 68 weeks, the average weight loss on the maintenance dose of 2.4 mg per week was 15%